| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $163.8M | +0.9% | -0.5% |
| Cost of Revenue | $129.3M | +1.4% | -0.2% |
| Gross Profit | $34.5M | -0.8% | -1.8% |
| R&D Expense | $26.1M | +3.4% | +11.3% |
| SG&A Expense | $22.5M | -2.8% | +0.4% |
| Operating Income | -$14.1M | -3.6% | -31.9% |
| Pre-tax Income | -$12.6M | -7.9% | -27.6% |
| Income Tax | $1.0M | -31.9% | +53.8% |
| Net Income | -$13.8M | -3.7% | -27.6% |
| EPS (Basic) | -$0.46 | -2.2% | -24.3% |
| EPS (Diluted) | -$0.46 | -2.2% | -24.3% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $190.3M | -3.1% | +12.3% |
| Accounts Receivable | $38.3M | +32.1% | +34.8% |
| Inventory | $199.0M | -0.5% | +5.8% |
| Current Assets | $452.8M | -6.1% | +13.4% |
| Total Assets | $976.4M | -2.6% | -12.5% |
| Current Liabilities | $136.4M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$6.3M | — | — |
| Capital Expenditures | $36.9M | — | — |
| Investing Cash Flow | $88.2M | — | — |
| Financing Cash Flow | -$44.6M | — | — |
| Free Cash Flow | -$43.1M | — | — |
| -12.2% |
| Long-term Debt | $1.3M | -37.0% | -92.5% |
| Total Liabilities | $176.2M | -4.0% | -23.4% |
| Stockholders' Equity | $800.2M | -2.3% | -9.7% |